These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 23641775)

  • 21. What influences family physicians' cancer screening decisions when practice guidelines are unclear or conflicting?
    Tudiver F; Guibert R; Haggerty J; Ciampi A; Medved W; Brown JB; Herbert C; Katz A; Ritvo P; Grant B; Goel V; Smith P; O'Beirne M; Williams JI; Moliner P
    J Fam Pract; 2002 Sep; 51(9):760. PubMed ID: 12366894
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Physician-office vs home uptake of colorectal cancer screening using FOBT/FIT among screening-eligible US adults.
    Chido-Amajuoyi OG; Sharma A; Talluri R; Tami-Maury I; Shete S
    Cancer Med; 2019 Dec; 8(17):7408-7418. PubMed ID: 31637870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of health insurance coverage in cancer screening utilization.
    Robinson JM; Shavers V
    J Health Care Poor Underserved; 2008 Aug; 19(3):842-56. PubMed ID: 18677074
    [TBL] [Abstract][Full Text] [Related]  

  • 24. General practitioners' perceptions of population based bowel screening and their influence on practice: a qualitative study.
    Dawson G; Crane M; Lyons C; Burnham A; Bowman T; Perez D; Travaglia J
    BMC Fam Pract; 2017 Mar; 18(1):36. PubMed ID: 28298185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Uptake of cancer screening services among middle and older ages in Ireland: the role of healthcare eligibility.
    Connolly S; Whyte R
    Public Health; 2019 Aug; 173():42-47. PubMed ID: 31254676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Temporal trends and regional disparities in cancer screening utilization: an observational Swiss claims-based study.
    Bähler C; Brüngger B; Ulyte A; Schwenkglenks M; von Wyl V; Dressel H; Gruebner O; Wei W; Blozik E
    BMC Public Health; 2021 Jan; 21(1):23. PubMed ID: 33402140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Colorectal cancer screening using the faecal occult blood test (FOBt): a survey of GP attitudes and practices in the UK.
    Damery S; Clifford S; Wilson S
    BMC Fam Pract; 2010 Mar; 11():20. PubMed ID: 20214769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adherence to recommended health checks by women in mid-life: data from a prospective study of women across Australia.
    Byles J; Leigh L; Chojenta C; Loxton D
    Aust N Z J Public Health; 2014 Feb; 38(1):39-43. PubMed ID: 24494944
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Different faecal sampling methods alter the acceptability of faecal occult blood testing: a cross sectional community survey.
    Ellis RJ; Wilson S; Holder RL; McManus RJ
    Eur J Cancer; 2007 Jun; 43(9):1437-44. PubMed ID: 17475476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adherence to and predictors of participation in colorectal cancer screening with faecal occult blood testing in Spain, 2009-2011.
    Ricardo-Rodrigues I; Jiménez-García R; Hernández-Barrera V; Carrasco-Garrido P; Jiménez-Trujillo I; López-de-Andrés A
    Eur J Cancer Prev; 2015 Jul; 24(4):305-12. PubMed ID: 25304027
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patterns in prostate-specific antigen test use and digital rectal examinations in the Behavioral Risk Factor Surveillance System, 2002-2006.
    Ross LE; Taylor YJ; Richardson LC; Howard DL
    J Natl Med Assoc; 2009 Apr; 101(4):316-24. PubMed ID: 19397221
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An Out-of-Pocket Cost Removal Intervention on Fecal Occult Blood Test Attendance.
    Tabuchi T; Murayama H; Hoshino T; Nakayama T
    Am J Prev Med; 2017 Aug; 53(2):e51-e62. PubMed ID: 28236518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Self-reported prevalence of prostate-specific antigen testing in South Australia: a community study.
    Pinnock CB; Weller DP; Marshall VR
    Med J Aust; 1998 Jul; 169(1):25-8. PubMed ID: 9695698
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparing acculturation scales and their relationship to cancer screening among older Mexican-American women.
    Suarez L; Pulley L
    J Natl Cancer Inst Monogr; 1995; (18):41-7. PubMed ID: 8562221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Accuracy of self-reported cancer-screening histories: a meta-analysis.
    Rauscher GH; Johnson TP; Cho YI; Walk JA
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):748-57. PubMed ID: 18381468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Australian general practitioners' views and use of colorectal cancer screening tests.
    Sladden MJ; Ward JE
    Med J Aust; 1999 Feb; 170(3):110-3. PubMed ID: 10065121
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between CBE, FOBT, and Pap smear adherence and mammography adherence among older low-income women.
    Augustson EM; Vadaparampil ST; Paltoo DN; Kidd LR; O'Malley AS
    Prev Med; 2003 Jun; 36(6):734-9. PubMed ID: 12744918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Type of health care coverage and the likelihood of being screened for cancer.
    Gordon NP; Rundall TG; Parker L
    Med Care; 1998 May; 36(5):636-45. PubMed ID: 9596055
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reducing income-related inequities in colorectal cancer screening: lessons learned from a retrospective analysis of organised programme and non-programme screening delivery in Winnipeg, Manitoba.
    Decker KM; Demers AA; Nugent Z; Biswanger N; Singh H
    BMJ Open; 2016 Feb; 6(2):e009470. PubMed ID: 26908517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of appropriate colorectal cancer screening and preferences for receiving screening advice among people attending outpatient clinics.
    Dodd N; Mansfield E; Carey M; Oldmeadow C
    Aust N Z J Public Health; 2018 Aug; 42(4):334-339. PubMed ID: 29528551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.